| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1665* | 2021 |
| Mortality after surgery in Europe: a 7 day cohort study RM Pearse, RP Moreno, P Bauer, P Pelosi, P Metnitz, C Spies, B Vallet, ... The Lancet 380 (9847), 1059-1065, 2012 | 1399 | 2012 |
| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1137 | 2020 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1020 | 2021 |
| Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial DC Angus, L Derde, F Al-Beidh, D Annane, Y Arabi, A Beane, ... Jama 324 (13), 1317-1329, 2020 | 815 | 2020 |
| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual … SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ... The lancet Respiratory medicine 2 (5), 395-404, 2014 | 726 | 2014 |
| COVID-19 and the liver: little cause for concern MN Bangash, J Patel, D Parekh The lancet Gastroenterology & hepatology 5 (6), 529-530, 2020 | 602 | 2020 |
| Interleukin-6 receptor antagonists in critically ill patients with Covid-19 Remap-Cap Investigators New England Journal of Medicine 384 (16), 1491-1502, 2021 | 600 | 2021 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 472 | 2021 |
| Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS) RCA Dancer, D Parekh, S Lax, V D'Souza, S Zheng, CR Bassford, D Park, ... Thorax 70 (7), 617-624, 2015 | 412 | 2015 |
| Elective surgery cancellations due to the COVID‐19 pandemic: global predictive modelling to inform surgical recovery plans CovidSurg Collaborative, D Nepogodiev, OM Omar, JC Glasbey, E Li, ... British journal of surgery 107 (11), 1440-1449, 2020 | 352 | 2020 |
| Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized … GD Perkins, C Ji, BA Connolly, K Couper, R Lall, JK Baillie, JM Bradley, ... Jama 327 (6), 546-558, 2022 | 294 | 2022 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 284 | 2022 |
| European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. Mortality … RM Pearse, RP Moreno, P Bauer, P Pelosi, P Metnitz, C Spies, B Vallet, ... Lancet 380 (9847), 1059-65, 2012 | 279 | 2012 |
| Pro-inflammatory effects of e-cigarette vapour condensate on human alveolar macrophages A Scott, ST Lugg, K Aldridge, KE Lewis, A Bowden, RY Mahida, ... Thorax 73 (12), 1161-1169, 2018 | 275 | 2018 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz, S Abdelbadiee, ... The Lancet 397 (10274), 605-612, 2021 | 221* | 2021 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 190 | 2021 |
| Cigarette smoke exposure and alveolar macrophages: mechanisms for lung disease ST Lugg, A Scott, D Parekh, B Naidu, DR Thickett Thorax 77 (1), 94-101, 2022 | 184 | 2022 |
| Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute hypoxemic … JJ McNamee, MA Gillies, NA Barrett, GD Perkins, W Tunnicliffe, D Young, ... Jama 326 (11), 1013-1023, 2021 | 142 | 2021 |
| Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na, K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury Q Wang, X Zheng, Y Cheng, YL Zhang, HX Wen, Z Tao, H Li, Y Hao, ... The Journal of Immunology 192 (8), 3765-3777, 2014 | 126 | 2014 |
Thickett dUniversity of birminghamVerified email at bham.ac.uk
